# Chronicle Labs

> Staging Environments for Enterprise AI Agents

| Field | Value |
|-------|-------|
| Website | https://chronicle-labs.com |
| YC Page | https://www.ycombinator.com/companies/chronicle-labs |
| Batch | Spring 2026 (YC company page) |
| Industry | B2B / B2B |
| Team Size | 2 |
| Location | San Francisco, CA, USA |
| Tags | AIOps, SaaS, AI |
| YC Partner | Pete Koomen (YC company page) |
| Emails | No public data found |

## The Idea

**Problem:** Enterprises deploying AI agents to production face risk of regressions when iterating on agent behavior; teams lack a way to replay real production events against new agent versions before deployment (chronicle-labs.com). Customer: Remedy Meds, with testimonial from Bayan, Director of Engineering (chronicle-labs.com).

**Approach:** Captures every event the agent sees in production and replays it as backtests so customers can test new behaviors safely (YC company page). Marketing claims: 100+ integrations, workflow discovery, scenario reconstruction from production data, real-time post-deployment monitoring, autonomous incident detection and reproduction, and test case generation from production errors (chronicle-labs.com).

**Differentiation:** Positioning is "staging environment" rather than evaluation/observability dashboard; emphasis on replaying real captured production events (not synthetic simulations) (chronicle-labs.com, YC page). Compared to Coval, which builds simulations modeled on autonomous-vehicle testing (TechCrunch, Jan 2025), Chronicle's stated mechanism is replay of captured production traffic. Compared to Braintrust and Langfuse, which are evaluation/observability-first (Braintrust comparison articles, 2026), Chronicle frames its product around backtesting before deploy.

**Business Model:** No pricing page is published on chronicle-labs.com; the site only offers "Book a demo" and "Talk To Us" CTAs (chronicle-labs.com). [Inferred]: Most likely monetization is enterprise annual contracts priced on event volume or per-agent, given the "100+ integrations" and enterprise positioning.

**TAM/SAM:** Global AI agents market estimated USD 7.63B in 2025 and USD 10.91B in 2026 (Grand View Research / Research and Markets, 2026 via search snippet). Agentic AI projected at USD 139.19B by 2034 at 40.5% CAGR (Fortune Business Insights, 2026 via search snippet). Gartner predicts 40% of enterprise applications will integrate task-specific AI agents by end of 2026, up from <5% in 2025 (Gartner press release, Aug 2025). No public TAM/SAM specific to "AI agent staging/backtesting" sub-segment was found.

**GTM / Distribution:** [Inferred]: Direct enterprise sales via "Book a demo" funnel, supported by YC network introductions; initial design-partner customer Remedy Meds confirmed on the website (chronicle-labs.com). No active job postings were located on the YC jobs page during research.

## Defensibility

Public defensibility evidence is limited. Disclosed assets:
- Working integration footprint claimed at 100+ sources (chronicle-labs.com); no integration list was published.
- One named design partner: Remedy Meds (chronicle-labs.com).
- No patents, proprietary datasets, or open-source repos identified; the founders' GitHub accounts contain no Chronicle Labs repos (github.com/ayman-saleh).

[Inferred]: Potential moat could develop via (a) accumulated production-event corpora captured per customer creating switching costs, and (b) integration breadth across enterprise agent stacks; both are unproven at this stage.

**Market structure:** No structural barrier identified at this stage. The product sits adjacent to AI observability/eval platforms, which are well-funded (see Competitive landscape). [Inferred]: Hyperscaler and existing eval vendors could ship comparable replay features without sales-channel conflict.

**Commoditization risk:** [Inferred]: The replay-from-production primitive is conceptually similar to traffic shadowing/recording techniques used in microservices (e.g., Speedscale, GoReplay). Existing AI observability vendors (Braintrust, Langfuse, Arize, LangSmith) already capture traces and could extend to replay/backtest workflows.

## Market & Traction

**1. Traction signals:**
- Customers: 1 named (Remedy Meds, with engineering director testimonial) (chronicle-labs.com).
- Marketing claims (company self-reported, no third-party verification): "30x production-derived scenario coverage," "12x more failure modes caught pre-launch," "99% reduction in workflow mapping time," "80% reduction in critical failures" (chronicle-labs.com).
- YC: Spring 2026 batch (YC company page).
- Press: No public press coverage found.
- Product Hunt: No launch found.
- Social: Company Twitter/X and LinkedIn pages — no dedicated company accounts surfaced in search; founder Ayman Saleh maintains @sir_aymansaleh on X (count not retrievable). Co-founder Rowan Zyadeh maintains @donutsandloops on X (count not retrievable).
- Discord/Slack community: No public data found.
- Web traffic / app installs: Not applicable; product is enterprise SaaS without public download endpoint.
- Job postings: No active YC jobs posting found at time of research; "Hiring: False" per company_data.
- Funding: No public funding announcement beyond YC standard backing inferred from batch participation. No public data found on round size.

**2. Competitive landscape:**
- **Coval (YC S24):** $3.3M seed led by MaC Venture Capital with General Catalyst, YC, Fortitude, Pioneer Fund, Lombard Street (TechCrunch, Jan 2025; coval.dev X post). Reported $550K revenue by June 2025 (GetLatka). Differentiator: simulation-based eval modeled on autonomous-vehicle testing, focused on voice and chat agents; Chronicle positions on replay of captured production events vs. synthetic simulations.
- **Braintrust:** Eval-first platform with CI/CD-integrated scoring and deployment blocking (Braintrust.dev, 2026). Funding/revenue: No public data found in search snippets reviewed. Differentiator: developer-workflow eval with merge-blocking; Chronicle is positioned as a pre-deploy staging product rather than a CI scoring layer.
- **Langfuse:** Open-source LLM observability with tracing, prompt management, multi-turn eval (Braintrust comparison, 2026). Acquired by Clickhouse in January 2026 (Braintrust article, 2026 via search snippet). Differentiator: open-source, self-hosted observability; Chronicle is closed-source and pre-deploy backtesting.
- **LangSmith (LangChain):** Default observability/eval tied to LangChain framework (Latitude blog, 2026 via search snippet). Funding/revenue: No public data found in search results. Differentiator: tight LangChain integration; Chronicle is framework-agnostic per "100+ integrations" claim.
- **Arize AI:** AI/ML observability platform listed among top agent observability tools for 2026 (Arize blog, 2026). Funding/revenue: No public data found in search snippets reviewed. Differentiator: production monitoring and eval at scale; Chronicle's stated angle is replay-before-deploy rather than continuous monitoring.

**3. Why now:** [Inferred]: The Gartner forecast of enterprise AI-agent integration jumping from <5% (2025) to 40% (end of 2026) (Gartner, Aug 2025) signals enterprise teams are moving agents into production at scale, creating demand for pre-deploy regression testing on real traffic. [Inferred]: Multi-step, tool-using agents (post-2024) have failure modes that single-prompt eval suites do not surface, opening space for replay-style backtesting.

## Founders & Team

**Ayman Saleh** — Co-founder & CEO
- Education: Master's, Stanford University; Bachelor's, Rutgers University–New Brunswick (RocketReach / ZoomInfo via search snippet).
- Prior roles (per RocketReach/ZoomInfo aggregator data via search snippet): Director of Software at FlightWave Aerospace; ML Engineer at Expedition Technology; Software Engineer at NVIDIA (depth estimation, network quantization for embedded GPUs); Quantitative Researcher at Deutsche Bank (anti-financial-crime ML, internal NLP trading system); Image Processing Engineer at NASA Jet Propulsion Laboratory; SWE/intern at Microsoft (VR/AR/MR perception).
- Twitter/X: @sir_aymansaleh (x.com/sir_aymansaleh) — count not retrievable.
- LinkedIn: linkedin.com/in/ayman-saleh (per YC page) — connection count not retrievable.
- GitHub: github.com/ayman-saleh — bio "Director of Software," org @flightwave, 9 followers; top public repo "ros-stream" (GST/ROS bridge) at 3 stars; mostly forks of yolov5, openpilot, jetson-inference, streetscape.gl (github.com/ayman-saleh).

**Rowan Zyadeh** — Co-founder & COO
- Education: No public data found.
- Prior roles: No public data found via search.
- Twitter/X: @donutsandloops (per YC page) — count not retrievable.
- LinkedIn: linkedin.com/in/zyadeh-rowan (per YC page) — headline and connection count not retrievable.
- GitHub: No public repos found in search.

**Co-founder relationship:** No public data on co-founder history. No shared employer or university surfaced in Phase 3 findings (Rowan Zyadeh's history was not retrievable from public search).

**Founder-market fit:** [Inferred]: Ayman Saleh's history spans ML deployment in latency- and reliability-critical domains — autonomous-vehicle perception (Expedition Technology UAVs, FlightWave drones), embedded GPU optimization (NVIDIA), and financial-systems ML (Deutsche Bank) — which is adjacent to the problem of catching agent regressions before production deploy. Rowan Zyadeh's domain background was not retrievable from public sources at time of research. No advisors, board members, or notable angel investors disclosed.

## Key Risks

**Crowded adjacent category:** AI agent eval/observability has at least four well-capitalized incumbents (Braintrust, Langfuse [acquired by Clickhouse, Jan 2026], LangSmith, Arize) plus a YC-backed direct competitor Coval ($3.3M seed, $550K reported revenue by June 2025; TechCrunch, GetLatka). Chronicle's "staging/backtesting" framing is a positioning differentiation; whether it is a durable product wedge versus a feature any of the above could ship is unverified.

**Single named customer:** Only Remedy Meds is publicly disclosed (chronicle-labs.com). Customer concentration and design-partner-vs-paying status is not disclosed.

**Co-founder public footprint asymmetry:** Rowan Zyadeh has no retrievable LinkedIn, GitHub, or prior-company history in public search results, while Ayman Saleh has a substantial documented track record. The COO's domain expertise cannot be assessed from public sources.

**Marketing-stat verifiability:** Quantitative claims on the marketing site ("30x scenario coverage," "12x more failure modes," "99% reduction in workflow mapping," "80% reduction in critical failures") are presented without methodology, sample size, or third-party validation (chronicle-labs.com).

**Name collision:** Multiple unrelated entities use "Chronicle Labs" — including Chronicle Protocol (oracle infrastructure / MakerDAO origin) at chroniclelabs.org and Chronicle (presentation software) at chroniclehq.com, which raised funds from Accel and Square Peg in 2023 (TechCrunch, Feb 2023). This will create SEO and brand-disambiguation friction for the YC company.

## Key Facts

| Dimension | Data |
|-----------|------|
| TAM | Global AI agents market USD 7.63B (2025) → USD 10.91B (2026) (Research and Markets / Grand View Research, 2026 via search snippet); agentic AI USD 139.19B by 2034 at 40.5% CAGR (Fortune Business Insights, 2026 via search snippet) |
| SAM | No public data found for AI-agent staging/backtesting sub-segment |
| Traction | 1 named customer: Remedy Meds (chronicle-labs.com); YC Spring 2026 batch (YC page); marketing claims "30x scenario coverage / 12x failure modes / 99% workflow mapping / 80% critical-failure reduction" (chronicle-labs.com, company self-reported) |
| Revenue Signal | No public data found (no pricing page on chronicle-labs.com; no funding announcement located) |
| Founders | Ayman Saleh (CEO): Stanford MS, Rutgers BS, Director of Software at FlightWave; prior NVIDIA, Deutsche Bank, NASA JPL, Microsoft (RocketReach/ZoomInfo via search snippet). Rowan Zyadeh (COO): public background not retrievable |
| Competitors | Coval ($3.3M seed, $550K rev June 2025, simulation-based agent eval; TechCrunch Jan 2025, GetLatka); Braintrust (eval-first w/ CI scoring; funding unknown; Braintrust.dev 2026); Langfuse (open-source observability, acquired by Clickhouse Jan 2026 via search snippet); LangSmith (LangChain-tied eval, funding unknown); Arize (production AI observability, funding unknown; Arize blog 2026) |
| Moat Signals | No public data found (no patents, no public repos, no disclosed proprietary dataset) |
| Risk Factors | Crowded adjacent category w/ funded incumbents, single named customer, name collision with Chronicle Protocol/Chronicle (presentations) |
| Founder Reach | Ayman Saleh: X @sir_aymansaleh (count not retrievable), LinkedIn ayman-saleh (count not retrievable), GitHub ayman-saleh 9 followers / top repo 3 stars (github.com/ayman-saleh). Rowan Zyadeh: X @donutsandloops (count not retrievable), LinkedIn zyadeh-rowan (count not retrievable), GitHub no public data found |
| Distribution Signals | No Product Hunt launch found; no press coverage found; no active YC job postings at time of research; "Book a demo" / "Talk To Us" CTAs only (chronicle-labs.com) |
| Emails | No public data found |

Sources:
- [Chronicle Labs](https://chronicle-labs.com/)
- [Chronicle Labs YC page](https://www.ycombinator.com/companies/chronicle-labs)
- [Ayman Saleh GitHub](https://github.com/ayman-saleh)
- [Ayman Saleh @sir_aymansaleh](https://x.com/sir_aymansaleh)
- [Ayman Saleh RocketReach (FlightWave Director of Software)](https://rocketreach.co/ayman-saleh-email_71138520)
- [Coval YC page](https://www.ycombinator.com/companies/coval)
- [Coval — TechCrunch, Jan 2025](https://techcrunch.com/2025/01/23/coval-evaluates-ai-voice-and-chat-agents-like-self-driving-cars/)
- [Coval revenue — GetLatka](https://getlatka.com/companies/coval.dev)
- [Coval $3.3M seed announcement (X)](https://x.com/covaldev/status/1882471030972665935)
- [Gartner — 40% of enterprise apps with task-specific AI agents by 2026](https://www.gartner.com/en/newsroom/press-releases/2025-08-26-gartner-predicts-40-percent-of-enterprise-apps-will-feature-task-specific-ai-agents-by-2026-up-from-less-than-5-percent-in-2025)
- [AI Agents Market — Research and Markets](https://www.researchandmarkets.com/reports/6103459/ai-agents-market-report)
- [Agentic AI Market — Fortune Business Insights](https://www.fortunebusinessinsights.com/agentic-ai-market-114233)
- [Braintrust — Best AI Agent Observability Tools 2026](https://www.braintrust.dev/articles/best-ai-agent-observability-tools-2026)
- [Braintrust — Langfuse alternatives 2026](https://www.braintrust.dev/articles/langfuse-alternatives-2026)
- [Pete Koomen — YC Group Partner](https://www.linkedin.com/in/petekoomen)
- [Chronicle (presentations) — TechCrunch, Feb 2023 (name-collision reference)](https://techcrunch.com/2023/02/21/chronicle/)
